Open AccessA New Natural Antimycotic Agent is Effective Against Oropharyngeal Candidiasis: The VIPROCAN Study
Author(s) -
Josefa Carrión-Navarro,
Alejandra Argüelles,
María Lara Martínez-Gimeno,
Alejandro Tovar Lozada,
Ángel Ayuso-Sacido,
Cristóbal Belda-Iniesta,
Mercedes Arnás-Rodríguez,
Noemí García-Romero
Publication year - 2022
Publication title -
the open dentistry journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 25
ISSN - 1874-2106
DOI - 10.2174/18742106-v16-e2202010
Subject(s) - toothpaste , incidence (geometry) , candida albicans , antifungal , medicine , population , microbiology and biotechnology , dermatology , dentistry , biology , physics , environmental health , optics
Background: The incidence of community and nosocomial candidiasis has dramatically increased in the last two decades. There are multiple treatments for this infection, but the toxicity of some and the induction of resistant strains require the development of new compounds. Objectives: With the aim of reducing the Candida population in the oropharyngeal cavity, we have formulated a toothpaste with VG-01 agent, composed of a mixture of carnosic acid (CA) and propolis (PP). Methods: We investigated the ability of VG-01 toothpaste to minimize and stabilize fungal presence in 21 patients diagnosed with clinical oropharyngeal candidiasis.Results: Our data indicate that VG-01 toothpaste showed an effect not only against the most frequent species of Candida, C. albicans , but also in the other species analyzed. 82% of patients stated that they would continue using it outside the study. Conclusion: Our data demonstrate that VG-01, composed of CA and PP is a potential antimycotic agent effective against the most common species that cause oropharyngeal candidiasis present in clinical practice.